Rodman & Renshaw Archives - Page 6 of 44

MondayNov 03, 2008 6:43 am

Global Med Technologies, Inc. (OTC BB: GLOB)

Global Med Technologies, Inc. (OTC BB: GLOB), an international medical software company, is focused on developing regulated and non-regulated software products and services for application in the medical field. The company’s products are currently deployed in 20 countries and serve more than 1,600 transfusion centers, blood banks and laboratories. Global Med’s U.S. division provides Vein-to- Vein® tracking through its Donor Doc(TM), SafeTrace®, SafeTrace Tx® and ElDorado Donor(TM) software products. For further information, visit the Company's web site at www.wyndgate.com.

MondayNov 03, 2008 6:42 am

Global Brands Acquisition Corporation (AMEX: GQN)

Global Brands Acquisition Corporation (AMEX: GQN) is a company organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock acquisition, stock purchase, reorganization or similar business combination, one or more operating business. The Company's efforts in identifying a prospective target business will not be limited to a particular industry although the Company will focus its efforts on acquiring an operating business in the branded consumer industry. Units of the young company were first listed on the AMEX on December 7, 2007. For further information, visit the company website at: www.enterpriseacq.com.

MondayNov 03, 2008 6:42 am

Glass Earth Gold Ltd. (TSX: GEL CN)

Glass Earth Gold Ltd. (TSX: GEL CN) is focused on discovering and developing gold and geothermal opportunities in New Zealand. Currently, the company is known to hold the largest on-shore gold exploration and prospecting permit portfolio in all of New Zealand. The company takes a scientific approach to gold exploration, leveraging its highly skilled international exploration team and the sophisticated use of new technology. For further information, visit the Company's web site at www.glassearthlimited.com.

MondayNov 03, 2008 6:41 am

Gilead Sciences, Inc. (NASDAQ: GILD)

Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, is focused on discovering, developing, and commercializing novel medicines to address unmet medical needs. The company’s aim is to improve the care of patients suffering from life-threatening diseases with every new discovery and experimental drug candidate. Primary areas of focus include: antivirals, cardiovascular conditions and respiratory diseases. For further information, visit the Company's web site at www.gilead.com.

MondayNov 03, 2008 6:40 am

Geron Corporation (NASDAQ: GERN)

Geron Corporation (NASDAQ: GERN) is a biopharmaceutical company focused on developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including heart failure, spinal cord injury and diabetes. The company’s mission is to develop an array of anti-cancer therapies based on telomerase inhibitors, telomerase therapeutic vaccines, and telomerase-based oncolytic viruses, and diagnostics based on telomerase detection. For further information, visit the Company's web site at www.geron.com.

MondayNov 03, 2008 6:40 am

GeoResources, Inc. (NASDAQ: GEOI)

GeoResources, Inc. (NASDAQ: GEOI) owns and operates producing oil and gas properties in the Gulf Coast, Permian Basin, Rocky Mountains and Williston Basin through its three subsidiaries G3 Operating, LLC and Southern Bay Operating, LLC. The company leverages its management’s expertise in mergers and acquisitions, which is further enhanced by relationships with investment and commercial bankers, institutional investors, brokers and principals. For further information, visit the Company's web site at www.georesourcesinc.com.

MondayNov 03, 2008 6:39 am

Geologix Explorations Inc. (TSX: GIX CN)

Geologix Explorations Inc. (TSX: GIX CN), a mineral exploration company, is committed to acquiring, exploring and developing gold properties in North and South America, as well as Mexico. Their projects include: San Agustin, La Casita, Consejo, Silver Cloud, QC Property, RO Property, OZ Property, Geologix-Newmont Alliance, Liscay Property, Cayhua, San Felipe, Sura, Patcorral, and Toro Blanco. The Company’s management has extensive expertise in the mining industry and have track record of brning early stage exploration prospects to final feasibility and ultimately to production. For further information, visit the Company's web site at http://www.geologix.ca.

MondayNov 03, 2008 6:39 am

Gentium S.p.A. (NASDAQ: GENT)

Gentium S.p.A. (NASDAQ: GENT), a biopharmaceutical company, specializes in discovering, researching, developing and manufacturing active ingredients derived from natural sources as potential therapeutic agents. The company focuses on developing relationships with industrial and academic institutions and intends to discover further beneficial effects of its products as well as develop pharmaceuticals with a broader range of treatment indications. For further information, visit the Company's web site at http://www.gentium.com.

MondayNov 03, 2008 6:39 am

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company, focuses on developing and commercializing a varied, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs. The company’s business strategy is to utilize new insights from molecular and cancer biology to understand the effectiveness and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment. For further information, visit the Company's web site at www.ziopharm.com.

MondayNov 03, 2008 6:38 am

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC)

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC) is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Genesis is a major pharmaceutical company in China producing tablets, capsules, and granules for both western and Chinese herbal- based medical drugs. The company has recently appointed Michael Marks to its Board of Directors and is looking to capitalize on the international pharmaceutical market.

Site Search

Company Search

Tag: Rodman & Renshaw

Global Med Technologies, Inc. (OTC BB: GLOB)

Global Brands Acquisition Corporation (AMEX: GQN)

Glass Earth Gold Ltd. (TSX: GEL CN)

Gilead Sciences, Inc. (NASDAQ: GILD)

Geron Corporation (NASDAQ: GERN)

GeoResources, Inc. (NASDAQ: GEOI)

Geologix Explorations Inc. (TSX: GIX CN)

Gentium S.p.A. (NASDAQ: GENT)

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC)

Market Basics

Newsletter Publishers

Public Companies